Matthew H. Samore, MD

Director
University of Utah

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-193) Risk Factors Associated with Patients Diagnosed with Clostridioides difficile Infection with no Documented Antibiotic Exposures
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-194) Evolution of Clostridioides difficile Antimicrobial Susceptibility within the epidemic REA Group BI (RT027) and the endemic REA group Y (RT014/020)
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-196) Differences in Clostridioides difficile Molecular Epidemiology and Antimicrobial Susceptibility at Two Veterans Affairs Hospitals
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-329) Estimating changes in MRSA infection rates due to changes in facility MRSA precautions
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-373) The VREy Resistant Enterococcus: Retracing VRE Transmission and Contamination Events in Healthcare Settings
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT